Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

OBJECTIVES: Hydroxychloroquine is an antimalarial agent that has been used in systemic lupus erythematosus and rheumatoid arthritis treatment for many years. Recently, novel mechanisms of action have been proposed, thereby broadening the therapeutic perspective of this medication. The purpose of thi...

Full description

Bibliographic Details
Main Authors: Juliana Cruz da Silva, Henrique Ataide Mariz, Laurindo Ferreira da Rocha Júnior, Priscilla Stela Santana de Oliveira, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte, Ivan da Rocha Pitta, Suely Lins Galdino, Maira Galdino da Rocha Pitta
Format: Article
Language:English
Published: Elsevier España 2013-06-01
Series:Clinics
Subjects:
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Th17 cells
Hydroxychloroquine
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600766

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600766

Similar Items